Uroplasty Inc (UPI.OQ)
UPI.OQ on NASDAQ Stock Exchange Capital Market
2.27USD
31 Jul 2013
2.27USD
31 Jul 2013
Price Change (% chg)
$-0.01 (-0.44%)
$-0.01 (-0.44%)
Prev Close
$2.28
$2.28
Open
$2.29
$2.29
Day's High
$2.29
$2.29
Day's Low
$2.25
$2.25
Volume
500
500
Avg. Vol
20,049
20,049
52-wk High
$4.32
$4.32
52-wk Low
$1.69
$1.69
About
Uroplasty, Inc. is a medical device company that develops, manufactures and markets products for the treatment of voiding dysfunctions. The Company’s primary focus is on two products: the Urgent PC Neuromodulation system and Macroplastique Implants. The Urgent PC system is a United States Food and Drug Administration (FDA)-appro... (more)
Overall
| Beta: | 1.02 |
| Market Cap (Mil.): | $47.10 |
| Shares Outstanding (Mil.): | 20.93 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| UPI.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 27.50 | 37.76 |
| EPS (TTM): | -0.16 | -- | -- |
| ROI: | -17.82 | 9.26 | 18.76 |
| ROE: | -18.40 | 12.54 | 19.59 |
Uroplasty places CFO on leave, delays filing annual report
- Medical device maker Uroplasty Inc said it placed Chief Financial Officer Mahedi Jiwani on administrative leave pending a review of internal financial controls, and would delay filing its annual report for the year ended March 31.
Competitors
| Price | Change | |
|---|---|---|
| Pfizer Inc. (PFE.N) | $29.22 | -0.01 |
| Johnson & Johnson (JNJ.N) | $93.93 | +0.43 |
| Novartis AG (NOVN.VX) | CHF66.60 | +0.35 |
| GlaxoSmithKline plc (GSK.L) | 1,704.15p | +21.50 |
| Medtronic, Inc. (MDT.N) | $55.36 | +0.12 |
| Coloplast A/S (COLOb.CO) | kr.328.30 | +0.70 |
| Boston Scientific Corporation (BSX.N) | $11.36 | +0.44 |
| Allergan, Inc. (AGN.N) | $91.81 | +0.69 |
| Salix Pharmaceuticals, Ltd. (SLXP.OQ) | $74.43 | +0.53 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

